as a possible link in understanding memory and cognition in people with Down syndrome.
Stanford researchers believe that “PTZ and the other compounds may work because they block a neurotransmitter that slows brain function. That neurotransmitter is believed to work too well in Down syndrome patients, hampering learning and memory,” according to a news story in today’s San Jose Mercury News.
as a possible link in understanding memory and cognition in people with Down syndrome.
Stanford researchers believe that “PTZ and the other compounds may work because they block a neurotransmitter that slows brain function. That neurotransmitter is believed to work too well in Down syndrome patients, hampering learning and memory,” according to a news story in today’s San Jose Mercury News.